Bulletin Board Pr $ELTP We
Post# of 63696
| ||
7:30 AM | Elite Pharmaceuticals Reports Successful Pivotal Bioequivalence Study for Abuse Deterrent Product ELI-200 - GlobeNewswire |
$ELTP called 9/21/13 $0.16 Shares Outsta
| ||
7:30 AM | Elite Pharmaceuticals Reports Successful Pivotal Bioequivalence Study for Abuse Deterrent Product ELI-200 - GlobeNewswire |